Pharma-Bio Serv (PBSV) Consolidated Net Income (2010 - 2026)
Pharma-Bio Serv posted quarterly Consolidated Net Income of $32860.0 for Q1 2026, up 284.96% year-on-year from $8536.0 in Q1 2025, and up 32315.69% on a QoQ basis from -$102.0 in Q4 2025.
Pharma-Bio Serv (PBSV) has 16 years of Consolidated Net Income data on file, last reported at $32860.0 in Q1 2026.
- For the quarter ending Q1 2026, Consolidated Net Income rose 284.96% year-over-year to $32860.0; the trailing twelve-month figure through Jan 2026 stood at -$85697.0 (up 82.8% YoY), and the FY2025 full-year result was -$100463.0, up 87.08% from the prior year.
- Consolidated Net Income for Q1 2026 stood at $32860.0, up from -$102.0 in the prior quarter.
- Across five years, Consolidated Net Income topped out at $526242.0 in Q3 2023 and bottomed at -$309194.0 in Q3 2024.
- The 5-year median for Consolidated Net Income is $32860.0 (2026), against an average of $86004.9.
- The widest annual swing landed in 2024, when Consolidated Net Income sank 163.48%; it then jumped 284.96% in 2026.
- A 5-year view of Consolidated Net Income shows it stood at $173379.0 in 2022, then sank by 127.19% to -$47148.0 in 2023, then surged by 134.17% to $16111.0 in 2024, then slumped by 100.63% to -$102.0 in 2025, then surged by 32315.69% to $32860.0 in 2026.
- The last three Consolidated Net Income figures came in at $32860.0 (Q1 2026), -$102.0 (Q4 2025), and -$213808.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 244.20 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 74.33 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 35.13 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 19.11 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 43.32 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -13.47 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 3.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 11.41 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | 32,860.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 32,860.00 |
| Oct 31, 2025 | -102.00 |
| Jul 31, 2025 | -213,808.00 |
| Apr 30, 2025 | 95,353.00 |
| Jan 31, 2025 | 8,536.00 |
| Oct 31, 2024 | 16,111.00 |
| Jul 31, 2024 | -309,194.00 |
| Apr 30, 2024 | -213,817.00 |
| Jan 31, 2024 | -270,719.00 |
| Oct 31, 2023 | -47,148.00 |
| Jul 31, 2023 | 526,242.00 |
| Apr 30, 2023 | 404,654.00 |
| Jan 31, 2023 | 426,432.00 |
| Oct 31, 2022 | 173,379.00 |
| Jul 31, 2022 | 288,034.00 |
| Apr 30, 2022 | 240,027.00 |
| Jan 31, 2022 | 305,244.00 |
| Oct 31, 2021 | -4.87 Mn |
| Jul 31, 2021 | 2.28 Mn |
| Apr 30, 2021 | 240,271.00 |
| Jan 31, 2021 | 268,032.00 |
| Oct 31, 2020 | 144,347.00 |
| Jul 31, 2020 | 692,114.00 |
| Apr 30, 2020 | 687,561.00 |
| Jan 31, 2020 | 526,900.00 |
| Oct 31, 2018 | 131,777.00 |
| Jul 31, 2018 | 8,812.00 |
| Apr 30, 2018 | -119,665.00 |
| Jan 31, 2018 | -191,698.00 |
| Oct 31, 2017 | 90,062.00 |
| Jul 31, 2017 | -162,982.00 |
| Apr 30, 2017 | -322,763.00 |
| Jan 31, 2017 | -382,135.00 |
| Oct 31, 2016 | -513,315.00 |
| Jul 31, 2016 | -130,473.00 |
| Apr 30, 2016 | 37,202.00 |
| Jan 31, 2016 | 350,011.00 |
| Oct 31, 2015 | 523,453.00 |
| Jul 31, 2015 | 453,973.00 |
| Apr 30, 2015 | 359,007.00 |
| Jan 31, 2015 | 288,393.00 |
| Jul 31, 2014 | 597,060.00 |
| Apr 30, 2014 | 327,778.00 |
| Jan 31, 2014 | 661,933.00 |
| Oct 31, 2013 | 1.22 Mn |
| Jul 31, 2013 | 1.25 Mn |
| Apr 30, 2013 | 1.39 Mn |
| Jan 31, 2013 | 1.05 Mn |
| Oct 31, 2012 | 1.08 Mn |
| Jul 31, 2012 | 1.28 Mn |
| Apr 30, 2012 | 1.19 Mn |
| Jan 31, 2012 | 1.15 Mn |
| Oct 31, 2011 | 824,427.00 |
| Jul 31, 2011 | 1.50 Mn |
| Apr 30, 2011 | 479,692.00 |
| Jan 31, 2011 | 356,260.00 |
| Oct 31, 2010 | 183,163.00 |
| Jul 31, 2010 | 121,409.00 |